Risky Stem-Cell Treatments Come Under F.D.A. Scrutiny — Again by DENISE GRADY


Warning that unapproved stem-cell treatments put patients at risk, the F.D.A. is notifying clinics and manufacturers that flout its rules.

Published: April 3, 2019 at 02:00AM

from NYT Health https://ift.tt/2UfjXIc